Since their introduction, inter partes review
("IPR") proceedings have had a close association with
district court litigation. Indeed, litigation defendants are often
the petitioners who initiate IPR proceedings. Therefore, the effect
that an IPR can have on concurrent or potential litigation is an
important consideration for petitioners.
Among the factors that petitioners must consider are the IPR
estoppel provisions. In particular, 35 U.S.C. § 315(e)(2)
dictates that once the Patent Trial and Appeal Board
("PTAB") has issued a final written decision on a
patent's claim(s), an IPR petitioner may not assert
"that the claim is invalid on any ground that the
petitioner raised or reasonably could have raised
during that post-grant review." Section 315(e)(2)
estoppel seemingly narrows the scope of the invalidity defenses
that may be asserted not only in subsequent district court
litigation, but also subsequent International Trade Commission
proceedings.